2000
DOI: 10.1039/b003094p
|View full text |Cite
|
Sign up to set email alerts
|

A versatile approach to the total synthesis of the pseudomonic acids

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
18
0

Year Published

2008
2008
2020
2020

Publication Types

Select...
6
1
1

Relationship

1
7

Authors

Journals

citations
Cited by 33 publications
(18 citation statements)
references
References 23 publications
0
18
0
Order By: Relevance
“…To confirm the structure of the novel metabolite, synthetic samples of the C-2 epimers 14 and 15 were prepared from a common alkene 19 in a cross-metathesis approach (Scheme 4). The known [26] secondary alcohol 18 was protected as the silyl ether. Reductive cleavage of the sultam auxiliary followed by Wittig olefination gave alkene 19 [27] in good yield.…”
Section: Structure Elucidation Of Mupiric Acidmentioning
confidence: 99%
“…To confirm the structure of the novel metabolite, synthetic samples of the C-2 epimers 14 and 15 were prepared from a common alkene 19 in a cross-metathesis approach (Scheme 4). The known [26] secondary alcohol 18 was protected as the silyl ether. Reductive cleavage of the sultam auxiliary followed by Wittig olefination gave alkene 19 [27] in good yield.…”
Section: Structure Elucidation Of Mupiric Acidmentioning
confidence: 99%
“…In 2000, Willis and coworkers published a novel total synthesis of pseudomonic acid C (144) that featured two Baeyer-Villiger oxidations to prepare the tetrahydropyran core of the molecule (151,Scheme 19). [91] Dihydroxylation and subsequent silyl protection of optically active ketone 147 gave compound 148, which was subjected to Baeyer-Villiger oxidation conditions to furnish lactone 149. Reductive opening of the lactone and capping of the resulting primary hydroxy group afforded secondary alcohol 150, which was oxidized to the corresponding ketone and subjected to a second Baeyer-Villiger oxidation to give lactone 151.…”
Section: Pseudomonic Acidsmentioning
confidence: 99%
“…Cross-coupling partner 172 was prepared from phenol 169 as . [91] Scheme 21. Highlights of the synthesis of the thiomarinol core 162 (Gao and Hall, 2005).…”
Section: Kinamycin Cmentioning
confidence: 99%
“…[170]; the vinca alkaloid (+)-catharanthine [171]; 2-epibotcinolide (primary alcohol to aldehyde TPAP oxidation also involved) [89]; the spirobicyclic sesquiterpene (±)-erythrodiene (nitro to ketone oxidation also involved; cf. 5.6.4) [172]; a secondary alcohol to an enone as a step in the synthesis of the biologically active sequiterpene (−)-diversifolin [51]; the cytotoxic fasicularin [173]; the limonoid fraxinellone [174]; the plasmodial pigment fuligorubin A [160]; the antifungal gambieric acids A and C (also a primary alcohol to aldehyde step) [90]; the ether toxin gambierol (two primary alcohol to aldehyde steps) [91]; the cytotoxic gymnocin-A (also a primary to aldehyde step) [92]; the alkaloid (±)-lapidilectine B [175]; the antiparasitic and insecticide (+)-milbemycin-b 1 , (involving both oxidation of a primary alcohol group to an aldehyde and, in a later step, of a secondary alcohol to a ketone) [98]; the acetogenin muricatetrocin C [176] and the sesquiterpenes nortrilobolide, thapsivillosin F and trilobolide [64]; the glutamate receptor neodysiherbaine [177]; the marine alkaloid norzoanthamine (primary alcohol to aldehyde step also) [99]; the anticarcinogenic agent ovalicin [178]; the cytotoxic agent phorboxazole (hemi-acetal to lactone) [179]; the antibacterial agent pseudomonic acid C [180]; the antifungal agent rapamycin (cf. 1.11) [181,182]; the antigen daphane diterpene (+)-resiniferatoxin [183]; the antitumour macrolide (+)-rhizoxin D [184]; the heliobactericidal (+)-spirolaxine methyl ether [185]; the SERCA thapsigargin inhibitors [112,152,153]; the antitumour agent tonatzitlolone [186] and the therapeutic hypercholesterolemia agent zaragozic acid A [187].…”
Section: Natural Product/pharmaceutical Syntheses Involving Secondarymentioning
confidence: 99%